Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-11-5
pubmed:abstractText
Thymoma is a thymic epithelial neoplasm which induces T cell development. However, the frequency of mature CD4(+) T cells in thymomas is lower than in normal thymi. Recently, CD4/CD8 lineage commitment has been elucidated in animal model. The zinc finger transcription factor Th-POK is a critical factor to CD4(+) T cell development in CD4/CD8 lineage commitment, whereas CD8(+) T cell development requires the transcription factor Runx3. These factors antagonize in CD4/CD8 lineage commitment. In this study, we examined Th-POK and Runx3 mRNA expression in the T cell subsets of human normal thymus and thymoma. A quantitative reverse transcriptase-polymerase chain reaction examination revealed that Th-POK expression in normal thymi was higher in the CD4(+)CD8(-) subset than in the CD4(+)CD8(+) and CD4(-)CD8(+) subsets. In thymomas, Th-POK expression in the CD4(+)CD8(-) subset was significantly lower than that in normal thymi, and was significantly correlated with the proportion of CD3(+) cells in the CD4(+)CD8(-) subset. However, Th-POK expressions of the CD3(+)CD4(+)CD8(+) and CD3(+)CD4(+)CD8(-) subsets were not impaired in thymomas compared to normal thymi. These results suggest that thymoma neoplastic epithelial cells can induce Th-POK expression similarly to the normal thymic epithelial cells. In addition, there was no significant difference in Runx3 expression between normal thymi and thymomas. Therefore, CD4/CD8 lineage commitment dependent on Th-POK and Runx3 system seems to be working even in the neoplastic environment formed by human thymomas.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1607-842X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
653-60
pubmed:meshHeading
pubmed-meshheading:19886737-Adult, pubmed-meshheading:19886737-Aged, pubmed-meshheading:19886737-Antigens, CD3, pubmed-meshheading:19886737-CD4-Positive T-Lymphocytes, pubmed-meshheading:19886737-CD8-Positive T-Lymphocytes, pubmed-meshheading:19886737-Cell Count, pubmed-meshheading:19886737-Cell Differentiation, pubmed-meshheading:19886737-Core Binding Factor Alpha 3 Subunit, pubmed-meshheading:19886737-DNA-Binding Proteins, pubmed-meshheading:19886737-Female, pubmed-meshheading:19886737-Gene Expression Regulation, pubmed-meshheading:19886737-Humans, pubmed-meshheading:19886737-Male, pubmed-meshheading:19886737-Middle Aged, pubmed-meshheading:19886737-T-Lymphocyte Subsets, pubmed-meshheading:19886737-T-Lymphocytes, pubmed-meshheading:19886737-Thymoma, pubmed-meshheading:19886737-Thymus Gland, pubmed-meshheading:19886737-Transcription Factors
pubmed:year
2009
pubmed:articleTitle
Regulation of Th-POK and Runx3 in T cell development in human thymoma.
pubmed:affiliation
Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
pubmed:publicationType
Journal Article